Lantern Pharma Inc. - LTRN
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 14
Latest filed: Aug 14, 2026
| Form | Count |
|---|---|
| 8-K | 7 |
| SCHEDULE 13G | 2 |
| SCHEDULE 13D/A | 2 |
| 4 | 2 |
| SCHEDULE 13G/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Aug 14, 2026 | 8-K | Aug 14, 2026 | 0001493152-26-037979 | View |
| Aug 04, 2026 | SCHEDULE 13G | — | 0000919574-26-004747 | View |
| Aug 03, 2026 | 8-K | Aug 03, 2026 | 0001493152-26-035864 | View |
| Jul 23, 2026 | SCHEDULE 13G/A | — | 0001104659-26-086180 | View |
| Jun 02, 2026 | 8-K | Jun 01, 2026 | 0001493152-26-026696 | View |
| May 15, 2026 | 8-K | May 15, 2026 | 0001493152-26-023758 | View |
| May 15, 2026 | SCHEDULE 13D/A | — | 0001813314-26-000008 | View |
| May 14, 2026 | 8-K | May 12, 2026 | 0001493152-26-023200 | View |
| May 14, 2026 | 4 | May 12, 2026 | 0001493152-26-023082 | View |
| May 14, 2026 | 4 | May 12, 2026 | 0001493152-26-023083 | View |
| Apr 16, 2026 | SCHEDULE 13D/A | — | 0001813314-26-000005 | View |
| Apr 10, 2026 | 8-K | Apr 09, 2026 | 0001493152-26-016047 | View |
| Apr 03, 2026 | SCHEDULE 13G | — | 0001104659-26-039486 | View |
| Mar 30, 2026 | 8-K | Mar 30, 2026 | 0001493152-26-013608 | View |